Skip to main content
Premium Trial:

Request an Annual Quote

Serologicals Subsidiary to Market Quantum Dot Technology

NEW YORK, March 4 (GenomeWeb News) - Chemicon International, a subsidiary of Serologicals, will market specific quantum dot-containing products from Quantum Dot for the detection of antibody-antigen interactions in immunological experiments, the companies said today.

 

This agreement will "add novel secondary antibody detection technologies to Chemicon's general reagents product portfolio," enabling researchers to study antigen presence in a variety of tissue and cell culture samples, the firms said.

 

Chemicon will sell these products under the Chemicon brand through its direct sales team in North America, Australia, UK, and "much of Europe," as well as through its worldwide network of distributors, the companies said.

Financial terms were not disclosed.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.